Ashley Eheim
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Biochemical and Molecular Research
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- Protein Degradation and Inhibitors 2
- Sphingolipid Metabolism and Signaling 2
- Biochemical and Molecular Research 2
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Ralf Lesche (4 shared papers)Krzysztof Brzezinka (3 shared papers)Andrea Haegebarth (4 shared papers)Marcus Bauser (3 shared papers)Claudia Merz (3 shared papers)Iain H. McKillop (3 shared papers)Laura W. Schrum (2 shared papers)Elizabeth Brandon‐Warner (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)Cancers (1 paper)Cancer Letters (1 paper)HPB (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesNorway
In The Last Decade
Ashley Eheim
11 papers receiving 422 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 123
- Molecular Biology 312
- Hematology 46
- Hepatology 27
- Aging 4
Countries citing papers authored by Ashley Eheim
This map shows the geographic impact of Ashley Eheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Eheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Eheim more than expected).
Fields of papers citing papers by Ashley Eheim
This network shows the impact of papers produced by Ashley Eheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Eheim. The network helps show where Ashley Eheim may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashley Eheim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 146 | |
| 2 | 2018 | 82 | |
| 3 | 2014 | 43 | |
| 4 | 2020 | 34 | |
| 5 | 2012 | 31 | |
| 6 | 2012 | 28 | |
| 7 | 2019 | 27 | |
| 8 | 2013 | 19 | |
| 9 | 2013 | 12 | |
| 10 | 2022 | 6 | |
| 11 | 2019 | 1 |
About Ashley Eheim
Ashley Eheim is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine and Hematology, having authored 11 papers that have together received 429 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), Sphingolipid Metabolism and Signaling (2 papers), Biochemical and Molecular Research (2 papers), Liver physiology and pathology (2 papers), HIV/AIDS drug development and treatment (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Liver Disease and Transplantation (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Cancer Research (123 citations), Molecular Biology (312 citations), Hematology (46 citations), Hepatology (27 citations) and Aging (4 citations). Ashley Eheim has collaborated with scholars based in Germany, United States and Norway. Frequent co-authors include Ralf Lesche, Krzysztof Brzezinka, Andrea Haegebarth, Marcus Bauser, Claudia Merz, Iain H. McKillop, Laura W. Schrum, Elizabeth Brandon‐Warner, Tracy L. Walling and Steven Ferrara. Their work appears in journals such as Molecular Cancer Therapeutics, Cancers, Cancer Letters, HPB and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.